Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis
- PMID: 15364433
- DOI: 10.1016/j.vaccine.2004.04.015
Vaccination with a plasmid DNA cocktail encoding the nucleosomal histones of Leishmania confers protection against murine cutaneous leishmaniosis
Abstract
Leishmania histones are relevant immunogens for the host immune system during both Leishmania infection and disease. In the present paper we have evaluated the prophylactic value of the four Leishmania infantum histones forming the nucleosomal core in the murine model of cutaneous leishmaniasis. In a first stage, the immune response elicited by the intramuscular injection of a mixture of four plasmid DNAs, encoding the L. infantum histones H2A, H2B, H3 and H4, was determined in BALB/c mice. It was found that the immunized animals developed a specific Th1 immune response, which was associated with an antigen-specific production of interferon (IFN-gamma) and a limited humoral response against histones (dominated by antibodies of the IgG2a isotype). According to the pure Th1-type immune response elicited by the DNA vaccination with Leishmania histones, vaccinated mice showed a solid immunity that efficiently controlled the Leishmania major infection. The protection in mice vaccinated with histone-DNAs was associated with a low humoral response against leishmanial antigens, an enhanced IFN-gamma production and little, if any, IL-4 production. The relative contribution of both CD8(+) and CD4(+) T cells to the IFN-gamma production, and the IL-12 dependence were also evaluated. All these data indicated that DNA vaccination with Leishmania histones genes results in a specific Th1-like response during L. major infection, and that both CD4(+) and CD8(+) T cells contribute to the resistance of vaccinated mice to cutaneous leishmaniasis.
Similar articles
-
Transitory or long-lasting immunity to Leishmania major infection: the result of immunogenicity and multicomponent properties of histone DNA vaccines.Vaccine. 2008 Feb 26;26(9):1155-65. doi: 10.1016/j.vaccine.2007.12.051. Epub 2008 Jan 22. Vaccine. 2008. PMID: 18255202
-
Vaccination with the Leishmania infantum acidic ribosomal P0 protein plus CpG oligodeoxynucleotides induces protection against cutaneous leishmaniasis in C57BL/6 mice but does not prevent progressive disease in BALB/c mice.Infect Immun. 2005 Sep;73(9):5842-52. doi: 10.1128/IAI.73.9.5842-5852.2005. Infect Immun. 2005. PMID: 16113303 Free PMC article.
-
Evaluation of DNA/DNA and prime-boost vaccination using LPG3 against Leishmania major infection in susceptible BALB/c mice and its antigenic properties in human leishmaniasis.Exp Parasitol. 2011 Mar;127(3):627-36. doi: 10.1016/j.exppara.2010.12.007. Epub 2010 Dec 25. Exp Parasitol. 2011. PMID: 21187087
-
Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states.Behring Inst Mitt. 1997 Feb;(98):153-9. Behring Inst Mitt. 1997. PMID: 9382736 Review.
-
Susceptibility to infectious diseases: Leishmania as a paradigm.J Infect Dis. 1999 Mar;179 Suppl 2:S305-8. doi: 10.1086/513843. J Infect Dis. 1999. PMID: 10081500 Review.
Cited by
-
Towards a more precise serological diagnosis of human tegumentary leishmaniasis using Leishmania recombinant proteins.PLoS One. 2013 Jun 12;8(6):e66110. doi: 10.1371/journal.pone.0066110. Print 2013. PLoS One. 2013. PMID: 23776617 Free PMC article.
-
Translating Observations From Leishmanization Into Non-Living Vaccines: The Potential of Dendritic Cell-Based Vaccination Strategies Against Leishmania.Front Immunol. 2018 Jun 4;9:1227. doi: 10.3389/fimmu.2018.01227. eCollection 2018. Front Immunol. 2018. PMID: 29922288 Free PMC article. Review.
-
Purification and biochemical characterization of two novel antigens from Leishmania major promastigotes.Korean J Parasitol. 2007 Dec;45(4):287-93. doi: 10.3347/kjp.2007.45.4.287. Korean J Parasitol. 2007. PMID: 18165711 Free PMC article.
-
Vaccines for leishmaniasis and the implications of their development for American tegumentary leishmaniasis.Hum Vaccin Immunother. 2020 Apr 2;16(4):919-930. doi: 10.1080/21645515.2019.1678998. Epub 2019 Nov 11. Hum Vaccin Immunother. 2020. PMID: 31634036 Free PMC article. Review.
-
Improving the serodiagnosis of canine Leishmania infantum infection in geographical areas of Brazil with different disease prevalence.Parasite Epidemiol Control. 2019 Nov 21;8:e00126. doi: 10.1016/j.parepi.2019.e00126. eCollection 2020 Feb. Parasite Epidemiol Control. 2019. PMID: 31832561 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials